DaVita Inc (DVA):企業の財務・戦略的SWOT分析

◆英語タイトル:DaVita Inc (DVA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH677FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥32,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

DaVita Inc (DVA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company caters to patients with chronic kidney failure and end-stage renal disease (ESRD). It also offers ancillary services, including therapy services, disease management services; vascular access services; ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. The company has operations in Arizona, California, Nevada, Florida, New Mexico and Colorado. DaVita is headquartered in Denver, Colorado, the US.

DaVita Inc Key Recent Developments

Feb 11,2021: DaVita 4th quarter 2020 results
Jan 05,2021: Early Risk Identification at core of innovative kidney care partnership between Renalytix, DaVita
Nov 23,2020: 14th Annual Tour DaVita raises nearly $1 million for Bridge of Life
Oct 29,2020: DaVita 3rd quarter 2020 results
Oct 05,2020: DAVITA: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
DaVita Inc – Key Facts
DaVita Inc – Key Employees
DaVita Inc – Key Employee Biographies
DaVita Inc – Major Products and Services
DaVita Inc – History
DaVita Inc – Company Statement
DaVita Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
DaVita Inc – Business Description
Business Segment: Other-Ancillary Services
Overview
Performance
Business Segment: U.S. Dialysis
Overview
Performance
Key Stats
DaVita Inc – SWOT Analysis
SWOT Analysis – Overview
DaVita Inc – Strengths
DaVita Inc – Weaknesses
DaVita Inc – Opportunities
DaVita Inc – Threats
DaVita Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
DaVita Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 11, 2021: DaVita 4th quarter 2020 results
Jan 05, 2021: Early Risk Identification at core of innovative kidney care partnership between Renalytix, DaVita
Nov 23, 2020: 14th Annual Tour DaVita raises nearly $1 million for Bridge of Life
Oct 29, 2020: DaVita 3rd quarter 2020 results
Oct 05, 2020: DAVITA: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
Sep 08, 2020: DaVita announces Shawn Guertin Will Join its Board of Directors
Aug 20, 2020: Clinical research trials underway to study COVID-19 impact on dialysis patients
Aug 11, 2020: DaVita announces Paula A. Price to join its Board of Directors
Aug 10, 2020: DAVITA: Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers
May 07, 2020: DaVita continues to support teammates during COVID-19 Crisis
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
DaVita Inc, Key Facts
DaVita Inc, Key Employees
DaVita Inc, Key Employee Biographies
DaVita Inc, Major Products and Services
DaVita Inc, History
DaVita Inc, Other Locations
DaVita Inc, Subsidiaries
DaVita Inc, Joint Venture
DaVita Inc, Key Competitors
DaVita Inc, Ratios based on current share price
DaVita Inc, Annual Ratios
DaVita Inc, Annual Ratios (Cont...1)
DaVita Inc, Annual Ratios (Cont...2)
DaVita Inc, Interim Ratios
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
DaVita Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
DaVita Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[DaVita Inc (DVA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Skyworth Digital Holdings Limited:企業の戦略・SWOT・財務情報
    Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Skyworth Digital Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Gibson Energy Inc (GEI):企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Memphasys Ltd (MEM)-製薬・医療分野:企業M&A・提携分析
    Summary Memphasys Ltd (Memphasys), formerly Nusep Holdings Ltd is a life science company that develops and sells pre-cast electrophoresis gels, separations equipment and consumables, analytical software, and other biological products. The company offers gels which include tris glycine, and tris hepe …
  • PepsiCo Inc:戦略・SWOT・企業財務分析
    PepsiCo Inc - Strategy, SWOT and Corporate Finance Report Summary PepsiCo Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Dolby Laboratories Inc (DLB):企業の財務・戦略的SWOT分析
    Dolby Laboratories Inc (DLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Lincoln Educational Services Corp (LINC):企業の財務・戦略的SWOT分析
    Summary Lincoln Educational Services Corp (Lincoln) is an educational service provider that operates schools, colleges and technical institutes. The organization offers student services including admissions, financial aid, academics, and career services. It provides educational programs in the areas …
  • Cosucra Groupe Warcoing SA:戦略・SWOT・企業財務分析
    Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report Summary Cosucra Groupe Warcoing SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Array BioPharma Inc (ARRY):製薬・医療:M&Aディール及び事業提携情報
    Summary Array BioPharma Inc (Array) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of targeted small-molecule drugs indicated for the treatment of cancer and inflammatory diseases. The company’s most advanced wholly-owned clinical stage drugs includ …
  • TUI AG (TUI1):企業の財務・戦略的SWOT分析
    TUI AG (TUI1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • BrainLAB AG:医療機器:M&Aディール及び事業提携情報
    Summary BrainLAB AG (Brainlab) is a medical technology company that develops, manufactures and markets medical technology facilitated by software that helps optimize treatment outcomes. The company provides technological solutions in radiosurgery and numerous surgical fields such as neurosurgery, or …
  • Mattel, Inc.:企業の戦略・SWOT・財務情報
    Mattel, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mattel, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Grundfos Holding AS:企業の戦略的SWOT分析
    Grundfos Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Liquor Control Board of Ontario:企業の戦略的SWOT分析
    Liquor Control Board of Ontario - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • GlycoMimetics Inc (GLYC):製薬・医療:M&Aディール及び事業提携情報
    Summary GlycoMimetics Inc (GlycoMimetics) is a clinical-stage biotechnology company that research, develops and commercializes small molecule drugs. The company’s products comprise rivipansel (GMI-1070), under phase III clinical trial is an anti-inflammatory compound to treat vaso-occlusive crisis o …
  • Blue Earth Inc:電力:M&Aディール及び事業提携情報
    Summary Blue Earth Inc (Blue Earth), formerly Genesis Fluid Solutions Holdings Inc is a renewable energy solutions provider. The company's services include energy efficiency solutions, alternative energy solutions, renewable energy solutions, acquisition, alternative and renewable energy plants fina …
  • The Central Bank of the Russian Federation:企業の戦略的SWOT分析
    The Central Bank of the Russian Federation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • AVT McCormick Ingredients Pvt. Ltd.:企業の戦略・SWOT・財務情報
    AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report Summary AVT McCormick Ingredients Pvt. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Allinky Biopharma SL:医療機器:M&Aディール及び事業提携情報
    Summary Allinky Biopharma SL (Allinky) is a developer of small molecules for the treatment of cancer and inflammatory diseases. The company offers research and development of basic and clinical sciences and discovery of novel therapies. Its therapeutic agents comprise active site drugs, target prote …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆